Hims & Hers Health (HIMS) Retained Earnings (2019 - 2026)
Hims & Hers Health's (HIMS) quarterly Retained Earnings came in at -$4.4 million in Q1 2026, down 2585.98% year-on-year from $177194.0 in Q1 2025, and up 96.13% quarter-over-quarter from -$113.8 million in Q4 2025.
Hims & Hers Health (HIMS) Retained Earnings (2019 - 2026) Analysis & Trends
Hims & Hers Health has disclosed Retained Earnings across 8 years of filings, most recently posting -$4.4 million for Q1 2026.
- Retained Earnings for Q1 2026 came in at -$4.4 million, down 2585.98% year-over-year; the trailing twelve-month figure through Mar 2026 was -$4.4 million (down 2585.98% YoY), and the FY2025 annual result was -$113.8 million, down 35014.81% from the prior year.
- Retained Earnings came in at -$4.4 million for Q1 2026 at Hims & Hers Health, up from -$113.8 million in the prior quarter.
- In the past five years, Retained Earnings ranged from a high of -$111000.0 in Q1 2023 to a low of -$368.2 million in Q4 2023.
- The 5-year median for Retained Earnings is -$324000.0 (2024), against an average of -$61.3 million.
- Peak annual rise in Retained Earnings reached 99.91% in 2024, while the deepest fall reached 201525.56% in 2024.
- Hims & Hers Health's Retained Earnings stood at -$277000.0 in 2022, then plunged by 132815.16% to -$368.2 million in 2023, then jumped by 99.91% to -$324000.0 in 2024, then tumbled by 35014.81% to -$113.8 million in 2025, then soared by 96.13% to -$4.4 million in 2026.
- The last three Retained Earnings figures came in at -$4.4 million (Q1 2026), -$113.8 million (Q4 2025), and -$134.4 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | -2.51 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | -772.00 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | -10.20 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | 683,383.23 |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 589.60 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | -2.13 Bn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | -2.91 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | -1.87 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | -4.41 Mn |
| 10 | Liquidia | 5.63 Bn | 5.40 Bn | 121.79 Mn | -573.45 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4.41 Mn |
| Dec 31, 2025 | -113.77 Mn |
| Sep 30, 2025 | -134.37 Mn |
| Jun 30, 2025 | -150.15 Mn |
| Mar 31, 2025 | -164,000.00 |
| Dec 31, 2024 | -324,000.00 |
| Sep 30, 2024 | -268.16 Mn |
| Jun 30, 2024 | -168,000.00 |
| Mar 31, 2024 | -162,000.00 |
| Dec 31, 2023 | -368.18 Mn |
| Sep 30, 2023 | -133,000.00 |
| Jun 30, 2023 | -258,000.00 |
| Mar 31, 2023 | -111,000.00 |
| Dec 31, 2022 | -277,000.00 |
| Sep 30, 2022 | -462,000.00 |
| Jun 30, 2022 | -468,000.00 |
| Mar 31, 2022 | -323,000.00 |
| Dec 31, 2021 | -137,000.00 |
| Sep 30, 2021 | -247.79 Mn |
| Jun 30, 2021 | -231.85 Mn |